Leukemia
Phase III
Accepting Patients
nct/study# NCT03589326 / PONATINIB-3001
A Phase 3, Randomized, Open-Label, Multicenter Study Comparing Ponatinib Versus Imatinib, Administered In Combination With Reduced-Intensity Chemotherapy, In Patients With Actively Diagnosed Philadelphia Chromosome?Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
Learn More
Leukemia
Phase II
Active
nct/study# NA / BST004
A Phase 2, Open Label, Single Arm, Multi‐Center Study To Assess The Efficacy And Safety Of BST‐236 As A Single Agent In Adults Unfit For Intensive Chemotherapy With Relapsed Or Refractory Acute Myeloid Leukemia Or Higher-Risk Myelodysplastic Syndrome?
Learn More
Leukemia
Phase II
Active
nct/study# NA / SY-1425-202
Phase II RARA(+) Actively Diagnosed/Untreated AML Study With Venetoclax/Azacitidine And SY-1425 With The Primary Objective To Characterize The Safety And Tolerability Of The Triplet Regimen.
Learn More
Leukemia
Phase III
Active
nct/study# NA / KB-ENTO-3001
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study To Assess The Efficacy And Safety Of Entospletinib In Combination With Intensive Induction And Consolidation Chemotherapy In Adults With Actively Diagnosed Nucleophosmin 1-Mutated (NPM1) Acute Myeloid Leukemia
Learn More
Leukemia
Phase III
Active
nct/study# NA / CMX-DS-003
A randomized, double-blind, placebo-controlled study to evaluate the efficacy
and safety of dociparstat sodium in combination with standard chemotherapy
for the treatment of ACTIVEly-diagnosed acute myeloid leukemia
Learn More
Leukemia
Phase I/II
Active
nct/study# NA / APTEVO
Phase 1-2 Study Of A Bispecific CD3xCD123 Antibody In Acute Myeloid Leukemia Patients
Learn More
